Details
| Stereochemistry | RACEMIC |
| Molecular Formula | C20H31NO2S.C6H8O7.H2O |
| Molecular Weight | 559.669 |
| Optical Activity | ( + / - ) |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
O.OC(=O)CC(O)(CC(O)=O)C(O)=O.O=C(OCCN1CCCCCC1)C(C2CCCCC2)C3=CSC=C3
InChI
InChIKey=YIIFJFQCZWTTCW-UHFFFAOYSA-N
InChI=1S/C20H31NO2S.C6H8O7.H2O/c22-20(23-14-13-21-11-6-1-2-7-12-21)19(18-10-15-24-16-18)17-8-4-3-5-9-17;7-3(8)1-6(13,5(11)12)2-4(9)10;/h10,15-17,19H,1-9,11-14H2;13H,1-2H2,(H,7,8)(H,9,10)(H,11,12);1H2
| Molecular Formula | C6H8O7 |
| Molecular Weight | 192.1235 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
| Molecular Formula | C20H31NO2S |
| Molecular Weight | 349.531 |
| Charge | 0 |
| Count |
|
| Stereochemistry | RACEMIC |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Optical Activity | ( + / - ) |
| Molecular Formula | H2O |
| Molecular Weight | 18.0153 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Cetiedil is effective potassium channel blocker used as a peripheral vasodilator to treat patients with painful crises in sickle cell anemia and pain in the extremities caused by an arterial disease. Known pharmacological properties of the drug include vascular smooth muscle relaxation, inhibition of phosphodiesterase with the consequent increase in circulating cyclic AMP concentration, blockade of the effect of bradykinin and serotonin, analgesia, inhibition of platelet aggregation and the decrease of plasma and blood viscosity and plasma fibrinogen level. The antisickling effect of cetiedil is explained mainly in the light of the changes it induces in the activities of membrane-bound ATPases and the permeability properties of the erythrocyte membrane to cations and anions.
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Synthesis and structure-activity relationships of cetiedil analogues as blockers of the Ca(2+)-activated K+ permeability of erythrocytes. | 2001 Sep 27 |
|
| An analysis of the mechanism by which cetiedil inhibits sickling. | 2002 Jan 18 |
|
| Inhibition of the antigen-induced activation of RBL-2H3 cells by cetiedil and some of its analogues. | 2004 Jan 12 |
|
| Inhibition of the antigen-induced activation of RBL-2H3 cells by charybdotoxin and cetiedil. | 2004 Jan 12 |
|
| Pharmacology of the human red cell voltage-dependent cation channel; Part I. Activation by clotrimazole and analogues. | 2004 May-Jun |
| Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 05:10:17 GMT 2023
by
admin
on
Sat Dec 16 05:10:17 GMT 2023
|
| Record UNII |
8VF7HHY5PF
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
165411860
Created by
admin on Sat Dec 16 05:10:17 GMT 2023 , Edited by admin on Sat Dec 16 05:10:17 GMT 2023
|
PRIMARY | |||
|
8VF7HHY5PF
Created by
admin on Sat Dec 16 05:10:17 GMT 2023 , Edited by admin on Sat Dec 16 05:10:17 GMT 2023
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
ANHYDROUS->SOLVATE | |||
|
|
PARENT -> SALT/SOLVATE |
